Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board
December 18, 2021 at 15:00 PM EST
BeiGene, a Beijing oncology company, began trading on the Shanghai STAR Board as the last step in its $3.5 billion IPO. The company is now listed in the US, Hong Kong, and Shanghai.
